Almonertinib
N-[5-[[4-(1-cyclopropylindol-3-yl)pyrimidin-2-yl]amino]-2-[2-(dimethylamino)ethyl-methylamino]-4-methoxyphenyl]prop-2-enamide
Molecular Identity
Almonertinib
N-[5-[[4-(1-cyclopropylindol-3-yl)pyrimidin-2-yl]amino]-2-[2-(dimethylamino)ethyl-methylamino]-4-methoxyphenyl]prop-2-enamide
PubChem CID: 121280087
2D Structure
Properties
C30H35N7O2
Molecular Formula
525.60
Molecular Weight
g/mol
525.2852
Exact Mass
Da
4.2
XLogP
Drug-like (Lipinski: < 5)
87.6
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
7
H-Bond Acceptors
823
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
Almonertinib1899921-05-1HS-10296AumolertinibAmeileEgfr T790M inhibitor HS-10296EQ143T4RS462G19EQ-143Hs 102962-Propenamide, N-(5-((4-(1-cyclopropyl-1H-indol-3-yl)-2-pyrimidinyl)amino)-2-((2-(dimethylamino)ethyl)methylamino)-4-methoxyphenyl)-2-Propenamide, N-[5-[[4-(1-cyclopropyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-RefChem:115556EGFR Tyrosine Kinase Inhibitor HS-10296HS-10297
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Almonertinib
Loading drug network...